SEARCH

SEARCH BY CITATION

References

  • Costello LC, Liu Y., Franklin RB, Kennedy MC. Zinc inhibition of mitochondrial aconitase and its importance in citrate metabolism of prostate epithelial cells. J Biol Chem. 1997;272: 2887528881.
  • Graff J.R., Konicek BW, McNulty AM, Wang Z., Houck K., Allen S., Paul JD, Hbaiu A., Goode RG, Sandusky GE, Vessella RL, Neubauer BL. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. J Biol Chem. 2000;275: 2450024505.
  • Gustavsson H., Welen K., Damber JE. Transition of an androgen-dependent human prostate cancer cell line into an androgen-independent subline is associated with increased angiogenesis. Prostate. 2005;62: 364373.
  • Gyorkey F., Min KW, Huff JA, Gyorkey P.. Zinc and magnesium in human prostate gland: normal, hyperplastic, and neoplastic. Cancer Res. 1967;27: 13481353.
  • Halkidou K., Gnanapragasam VJ, Mehta PB, Logan IR, Brady ME, Cook S., Leung HY, Neal DE, Robson CN. Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development. Oncogene. 2003;22: 24662477.
  • Hallowes RC, Bone EJ, Jones W.. A new dimension in the culture of human breast. In: Richards RJ, Rajan KT eds. Tissue Culture in Medical Research. Oxford, United Kingdom: Pergamon Press; 1980: 213220.
  • Hara T., Miyazaki J., Araki H., Yamaoka M., Kanzaki N., Kusaka M., Miyamoto M.. Novel mutations of androgen receptor: a possible mechanism of bicalutamide withdrawal syndrome. Cancer Res. 2003;63: 149153.
  • Hasenson M., Hartley-Asp B., Kihlfors C., Lundin A., Gustafsson JA, Pousette A.. Effect of hormones on growth and ATP content of a human prostatic carcinoma cell line, LNCaP-r. Prostate. 1985;7: 183194.
  • Horoszewicz JS, Leong SS, Kawinski E., Karr JP, Rosenthal H., Chu TM, Mirand EA, Murphy GP. LNCaP model of human prostatic carcinoma. Cancer Res. 1983;43: 18091818.
  • Iguchi K., Hamatake M., Ishida R., Usami Y., Adachi T., Yamamoto H., Koshida K., Uchibayashi T., Hirano K.. Induction of necrosis by zinc in prostate carcinoma cells and identification of proteins increased in association with this induction. Eur J Biochem. 1998;253: 766770.
  • Iguchi K., Otsuka T., Usui S., Ishii K., Onishi T., Sugimura Y., Hirano K.. Zinc and metallothionein levels and expression of zinc transporters in androgen-independent subline of LNCaP cells. J Androl. 2004;25: 154161.
  • Ishii K., Usui S., Sugimura Y., Yamamoto H., Yoshikawa K., Hirano K.. Inhibition of aminopeptidase N (AP-N) and urokinase-type plasminogen activator (uPA) by zinc suppresses the invasion activity in human urological cancer cells. Biol Pharm Bull. 2001a;24: 226230.
  • Ishii K., Usui S., Sugimura Y., Yoshida S., Hioki T., Tatematsu M., Yamamoto H., Hirano K.. Aminopeptidase N regulated by zinc in human prostate participates in tumor cell invasion. Int J Cancer. 2001b;92: 4954.
  • Joly-Pharaboz MO, Soave MC, Nicolas B., Mebarki F., Renaud M., Foury O., Morel Y., Andre JG. Androgens inhibit the proliferation of a variant of the human prostate cancer cell line LNCaP. J Steroid Biochem Mol Biol. 1995;55: 6776.
  • Kawada M., Inoue H., Arakawa M., Takamoto K., Masuda T., Ikeda D.. Highly tumorigenic human androgen receptor-positive prostate cancer cells overexpress angiogenin. Cancer Sci. 2007;98: 350356.
  • Kawada M., Inoue H., Usami I., Takamoto K., Masuda T., Yamazaki Y., Ikeda D.. Establishment of a highly tumorigenic LNCaP cell line having inflammatory cytokine resistance. Cancer Lett. 2006;242: 4652.
  • Kokontis J., Takakura K., Hay N., Liao S.. Increased androgen receptor activity and altered c-myc expression in prostate cancer cells after long-term androgen deprivation. Cancer Res. 1994;54: 15661573.
  • Lee JY, Kim JH, Hong SH, Cherny RA, Bush AI, Palmiter RD, Koh JY. Estrogen decreases zinc transporter 3 expression and synaptic vesicle zinc levels in mouse brain. J Biol Chem. 2004;279: 86028607.
  • Mawson CA, Fischer MI. The occurrence of zinc in the human prostate gland. Can J Med Sci. 1952;30: 336339.
  • Onishi T., Yamakawa K., Franco OE, Kawamura J., Watanabe M., Shiraishi T., Kitazawa S.. Mitogen-activated protein kinase pathway is involved in alpha6integrin gene expression in androgen-independent prostate cancer cells: role of proximal Sp1 consensus sequence. Biochim Biophys Acta. 2001;1538: 218227.
  • Palmiter RD, Cole TB, Quaife CJ, Findley SD. ZnT-3, a putative transporter of zinc into synaptic vesicles. Proc Natl Acad Sci U S A. 1996;93: 1493414939.
  • Shiina H., Igawa M., Ishibe T.. Clinical study on estramustine binding protein (EMBP) in human prostate. Prostate. 1996;29: 169176.
  • So A., Gleave M., Hurtado-Col A., Nelson C.. Mechanisms of the development of androgen independence in prostate cancer. World J Urol. 2005;23: 19.
  • Taplin ME, Ho SM. Clinical review 134: the endocrinology of prostate cancer. J Clin Endocrinol Metab. 2001;86: 34673477.
  • Tepper CG, Boucher DL, Ryan PE, Ma AH, Xia L., Lee LF, Pretlow TG, Kung HJ. Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. Cancer Res. 2002;62: 66066614.
  • Veldscholte J., Ris-Stalpers C., Kuiper GG, Jenster G., Berrevoets C., Claassen E., van Rooij HC, Trapman J., Brinkmann AO, Mulder E.. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem Biophys Res Commun. 1990;173: 534540.
  • Wan XS, Zhou Z., Steele V., Kopelovich L., Kennedy AR. Establishment and characterization of sublines of LNCaP human prostate cancer cells. Oncol Rep. 2003;10: 15691575.
  • Wang Y., Revelo MP, Sudilovsky D., Cao M., Chen WG, Goetz L., Xue H., Sadar M., Shappell SB, Cunha GR, Hayward SW. Development and characterization of efficient xenograft models for benign and malignant human prostate tissue. Prostate. 2005;64: 149159.
  • Wen Y., Hu MC, Makino K., Spohn B., Bartholomeusz G., Yan DH, Hung MC. HER-2/neu promotes androgen-independent survival and growth of prostate cancer cells through the Akt pathway. Cancer Res. 2000;60: 68416845.
  • Wu HC, Hsieh JT, Gleave ME, Brown NM, Pathak S., Chung LW. Derivation of androgen-independent human LNCaP prostatic cancer cell sublines: role of bone stromal cells. Int J Cancer. 1994;57: 406412.
  • Yeung F., Li X., Ellett J., Trapman J., Kao C., Chung LW. Regions of prostate-specific antigen (PSA) promoter confer androgen-independent expression of PSA in prostate cancer cells. J Biol Chem. 2000;275: 4084640855.
  • Zhau HY, Chang SM, Chen BQ, Wang Y., Zhang H., Kao C., Sang QA, Pathak SJ, Chung LW. Androgen-repressed phenotype in human prostate cancer. Proc Natl Acad Sci U S A. 1996;93: 1515215157.